Jade Biosciences, Inc. (JBIO)
NASDAQ · Manufacturing · Pharmaceutical preparations
$14.42−$0.3100 (−2.10%) on the dayAs of the close; data may be delayed.
JBIO price, last 12 months
Key stats
- Previous close
- $14.73
- Open
- $14.81
- Day range
- $14.39 – $15.20
- 52-week range
- $7.69 – $28.00
- Volume
- 396.8K
- Avg volume (20 days)
- 1M
- Market cap
- $917.1M
Performance
1W−14.9%
1M−32.4%
3M−34.5%
6M+3.4%
YTD−6.6%
1Y+77.6%
vs S&P 500, 1Y+60.8 pts
Technicals and fundamentals
About Jade Biosciences, Inc.
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $917.1M